Reimbursement policy for drugs and biologicals billed on CMS-1500 and UB-04 (JW/JZ modifiers)
Governs reimbursement rules for drugs and biologicals billed on CMS-1500 and UB-04 forms (including discarded amounts) for UnitedHealthcare Community Plan Medicaid products; affects all network and non-network providers submitting claims on these forms.
Reimbursement Guidelines: Updated to add JZ modifier requirement.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.